Castle Biosciences, Inc. (CSTL) vs Myriad Genetics, Inc. (MYGN)
- Castle Biosciences, Inc. CSTL 31.96 −5.44%
- Myriad Genetics, Inc. MYGN 3.98 −8.51%
Castle Biosciences, Inc. and Myriad Genetics, Inc. are both Diagnostics & Research companies. Castle Biosciences, Inc. is the larger, with a market value of $1.0B against $416.1M — 2.5× the size. Castle Biosciences, Inc. grew revenue faster over the last twelve months: 3.18% against −3.16%. Castle Biosciences, Inc. has the higher net margin (−5.43% vs −14.0%) and the higher return on invested capital (−9.40% vs −19.9%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 13 and Myriad Genetics, Inc. on 5.
Valuation
Profitability
| Metric | CSTL | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.26% | 68.83% | 50.89% |
| Operating margin | (8.99%) | (12.22%) | (8.57%) |
| Net margin | (5.43%) | (13.96%) | (6.37%) |
| Free cash flow margin | (0.13%) | (1.76%) | 0.00% |
| Return on equity | (4.20%) | (32.54%) | (2.92%) |
| Return on assets | (3.51%) | (17.11%) | (6.71%) |
| Return on invested capital | (9.40%) | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack